Skip to main content

Reciprocal Relationship Identified Between T2D, Asthma

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 11, 2024.

via HealthDay

WEDNESDAY, Sept. 11, 2024 -- There is a reciprocal relationship between asthma and type 2 diabetes (T2D), according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.

Nam Nhat Nguyen, M.D., from Taipei Medical University in Taiwan, and colleagues conducted a systematic review and meta-analysis to examine the interconnection between asthma and T2D and explore potential underlying factors and mechanisms. The meta-analysis included data on 17 million individuals from 14 studies conducted across continents and countries. Participants were mainly aged 50 to 70 years.

The researchers found a reciprocal relationship between asthma and diabetes: Compared with those without asthma, individuals with asthma were 28 percent more likely to develop T2D, and individuals with T2D were 83 percent more likely than those without T2D to develop asthma. There was an association for asthma severity with an increased risk for T2D, but no association was seen for asthma duration with T2D risk.

"Our findings have important implications for clinical practice. Firstly, this relationship emphasizes the need for greater awareness among patients with type 2 diabetes or asthma and their health care providers," Nguyen said in a statement. "Secondly, preventive strategies should be considered to lower the risk of type 2 diabetes in individuals with asthma."

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials

THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...

Increasing Proportion of U.S. Adults Unaware They Have Hypertension

MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...

Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM

MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.